ArticleCochrane evidence synthesis and methods2024
Adherence to PRISMA 2020 statement assessed through the expanded checklist in systematic reviews of interventions: A meta-epidemiological study.
Article in Cochrane evidence synthesis and methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Predictive Performance of Artificial Intelligence Algorithms for Gestational Diabetes Mellitus in Pregnant Women: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2026Pooled it
- Evaluating the quality of systematic reviews and meta-analyses published in behaviour analysis journals: An umbrella review.PloS one · 2026Pooled it
- Tools used to appraise the quality of studies included in systematic reviews and meta-analyses in human genetics: a systematic review.European journal of human genetics : EJHG · 2025Pooled it
- Reporting and methodological quality of systematic reviews underpinning clinical practice guidelines for low back pain: a meta-epidemiological study.Frontiers in pain research (Lausanne, Switzerland) · 2025Pooled it
- Reporting quality of systematic reviews published from 2011 to 2024 in theJournal of Korean biological nursing science · 2026Review
- Narrative review on decoding the crosstalk between lipid homeostasis and immune pathways in membranous nephropathy.BMC nephrology · 2025Review
- Article
- Adherence to PRISMA 2020 statement assessed through the expanded checklist in systematic reviews of interventions: A meta-epidemiological study.Cochrane evidence synthesis and methods · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement was developed to improve the reporting of systematic reviews (SRs) and meta-analyses. Due to the suboptimal reporting of the 2009 version, an update was performed and published in 2021. Despite having been evaluated in studies published before its publication, its adherence in SRs of interventions published after 2021 remains unclear. Objective: To assess PRISMA 2020 statement adherence and its uptake in SRs of interventions. Methods: We conducted a prospective cross-sectional study searching MEDLINE (PubMed), including a 10% random sample of all SRs involving human interventions published since January 2022 retrieved by our search process. We did not apply any restrictions. We assessed PRISMA 2020 statement uptake and its adherence using its expanded checklist. Results: We included 222 out of 945 studies. 67 (30.18%) used PRISMA 2020 statement. None adhered completely, with an average adherence of 42.64% (Min-Max: 14.29%-76.19%). Results and Methods sections had low adherence, with 40.57% (Min-Max: 10.45%-98.51%) and 25.55% (Min-Max: 7.46%-55.22%) respectively. The items with the least adherence were: certainty and reporting bias assessment, excluded studies characteristics and search strategy with 7.46% (5/67), 8.96% (6/67), 10.45% (7/67), and 11.94% (8/67) respectively. Discussion: As in previous studies, our study showed low adherence, mainly to the methods and results sections. However, our study showed a lower adherence, probably due to the use of the expanded checklist to assessed the tools adherence. Conclusion: We found a low adherence rate to the PRISMA 2020 expanded checklist. Further PRISMA dissemination and targeted audience training are needed to improve SR reporting and quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.